Matthew Paul Kowalsky - 29 Apr 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role: Chief Legal Officer
Signature: /s/ Matthew Paul Kowalsky
Issuer symbol: ENTA
Transactions as of: 29 Apr 2024
Net transactions value: $0
Form type: 4
Filing time: 01 May 2024, 16:27:12 UTC
Previous filing: 11 Aug 2023
Next filing: 27 Nov 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENTA	Stock Option (right to buy)	Award	$0	+150,000		$0.000000	150,000	29 Apr 2024	Common Stock	150,000	$13.25	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of such option will become exercisable on April 29, 2025 (the "Anniversary Date"), with the remainder to become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years from the Anniversary Date (in each case subject to the optionholder's continued employment).

Content

Twenty-five percent (25%) of such option will become exercisable on April 29, 2025 (the "Anniversary Date"), with the remainder to become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years from the Anniversary Date (in each case subject to the optionholder's continued employment).